BECTON, DICKINSON AND COMPANY

(BDX)
  Report
Real-time Estimate Cboe BZX  -  05/16 03:41:55 pm EDT
252.74 USD   +1.73%
08:09aBD Recognized by DiversityInc in Annual Ranking of Top US Companies for Diversity
AQ
05/13Embecta Fiscal Second-Quarter Results Fall on External Headwinds; Offers Downbeat Sales Outlook
MT
05/12BD Launches Fully Automated, High-Throughput Infectious Disease Molecular Diagnostic Platform in the U.S.
PR
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows:

- medical equipment (46.8%): surgical instruments (25.7% of net sales), pharmaceutical systems (19.3%), diabetes care products (12.2%), and other (42.8%);

- diagnostic materials (32.3%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.;

- clinical research and development tools (20.9%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc.

Net sales are distributed geographically as follows: the United States (54.2%), Europe, Middle East and Africa (23.5%), Asia 16.1%) and other (6.2%).

Number of employees : 75 000 people.
Sales per Business
20202021Delta
Medical8 680.0050.7%9 479.0046.8% +9.21%
Life Sciences4 675.0027.3%6 530.0032.3% +39.68%
Interventional3 762.0022%4 239.0020.9% +12.68%
USD in Million
Sales per region
20202021Delta
United States9 716.0056.8%10 969.0054.2% +12.9%
EMEA--4 751.0023.5%-
Greater Asia2 568.0015%3 272.0016.2% +27.41%
Other1 353.007.9%1 255.006.2% -7.24%
USD in Million
Managers
Name Title Age Since
Thomas Polen Chairman, President & Chief Executive Officer 48 2021
Chris DelOrefice Chief Financial Officer & Executive Vice President - 2021
William Sigmund Chief Medical Officer & Executive Vice President - 2018
Jerry Flasz Chief Information Officer & EVP-Global Services - -
Joseph Smith Chief Scientific Officer & Senior Vice President - 2021
Colleen Riley Chief Technology Officer & Senior Vice President - 2021
Michelle Quinn Chief Ethics & Compliance Officer, Senior VP - 2019
Francesca M. DeMartino Senior Vice President-Investor Relations - 2021
Gary Michael DeFazio Secretary & Senior Vice President - -
Tony Ezell Chief Marketing Officer & President-North America 52 2020
Members of the board
Name Title Age Since
Thomas Polen Chairman, President & Chief Executive Officer 48 2021
Bertram L. Scott Independent Director 69 2002
Claire M. Fraser-Liggett, Dr. Independent Director 66 2006
Marshall O. Larsen Independent Director 73 2012
Christopher Ian Montague Jones Independent Director 66 2010
Catherine M. Burzik Independent Director 71 2013
Robert Eckert Independent Director 60 2016
Tim Ring Independent Director 64 2017
Jeffrey Henderson Independent Director 57 2018
Carrie L. Byington, Dr. Independent Director 58 2021
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 364,639,629 282,872,623 77.6% 79,575,000 21.8% 77.6%
Shareholders
NameEquities%
The Vanguard Group, Inc. 23,015,595 8.08%
T. Rowe Price Associates, Inc. (Investment Management) 19,324,698 6.79%
SSgA Funds Management, Inc. 12,705,205 4.46%
Wellington Management Co. LLP 11,312,631 3.97%
Morgan Stanley Investment Management Ltd. 8,261,400 2.90%
BlackRock Fund Advisors 6,129,787 2.15%
Parnassus Investments LLC 5,097,664 1.79%
Generation Investment Management LLP 4,942,009 1.74%
Parnassus Investments 4,706,249 1.65%
Geode Capital Management LLC 4,499,909 1.58%
Markets and indexes
- Main Market
- S&P 500 / Stoxx Global 200
Stock Exchange Codes
- Bloomberg Code :  BDX:US
- Reuters Code :  BDX
- Datastream Code :  
Company contact information
Becton, Dickinson and Company
1 Becton Drive
NJ 07417-1880 Franklin Lakes, New Jersey

Phone : +1 800-284-6845
Fax :
web site : https://investors.bd.com/
Brand Portfolio
In partnership withAllbrands.markets
More brands of Becton, Dickinson and Company
Sector Other Medical Equipment, Supplies & Distribution
1st jan.Capi. (M$)
BECTON, DICKINSON AND COMPANY1.09%70 821
ABBOTT LABORATORIES-21.93%192 394
MEDTRONIC PLC-0.75%137 736
BAXTER INTERNATIONAL INC.-14.92%36 773
HOYA CORPORATION-26.45%35 552
DEXCOM, INC.-37.66%32 847
AMERISOURCEBERGEN CORPORATION15.05%32 025
SARTORIUS STEDIM BIOTECH-38.18%28 612
ZIMMER BIOMET HOLDINGS-7.56%24 116
TERUMO CORPORATION-18.66%23 136
WEST PHARMACEUTICAL SERVICES, INC.-34.98%22 591
FUJIFILM HOLDINGS CORPORATION-16.51%22 076
ALIGN TECHNOLOGY, INC.-58.08%21 713
STERIS PLC-11.19%21 645
AVANTOR, INC.-28.69%18 341
BIO-RAD LABORATORIES, INC.-33.55%15 049
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.-12.52%14 949
SYSMEX CORPORATION-44.95%13 858
INSULET CORPORATION-25.19%13 803
TELEFLEX INCORPORATED-15.23%13 060
REPLIGEN CORPORATION-43.21%8 337